These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27745551)

  • 21. The effect of low-dose furosemide in critically ill patients with early acute kidney injury: A pilot randomized blinded controlled trial (the SPARK study).
    Bagshaw SM; Gibney RTN; Kruger P; Hassan I; McAlister FA; Bellomo R
    J Crit Care; 2017 Dec; 42():138-146. PubMed ID: 28732314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetylcysteine and/or ascorbic acid versus placebo to prevent contrast-induced nephropathy in patients undergoing elective cardiac catheterization: The NAPCIN trial; A single-center, prospective, randomized trial.
    Habib M; Hillis A; Hammad A
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):55-61. PubMed ID: 26787567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors for contrast-induced acute kidney injury in high-risk patients given N-acetylcysteine prophylaxis.
    Poh WY; Omar MS; Tan HP
    Ann Saudi Med; 2018; 38(4):269-276. PubMed ID: 30078025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.
    Rashid ST; Salman M; Myint F; Baker DM; Agarwal S; Sweny P; Hamilton G
    J Vasc Surg; 2004 Dec; 40(6):1136-41. PubMed ID: 15622367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative Hypotension and Adverse Kidney-related Outcomes among Critically Ill Patients with Shock. A Multicenter, Prospective Cohort Study.
    Panwar R; Tarvade S; Lanyon N; Saxena M; Bush D; Hardie M; Attia J; Bellomo R; Van Haren F;
    Am J Respir Crit Care Med; 2020 Nov; 202(10):1407-1418. PubMed ID: 32614244
    [No Abstract]   [Full Text] [Related]  

  • 26. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
    Billings FT; Hendricks PA; Schildcrout JS; Shi Y; Petracek MR; Byrne JG; Brown NJ
    JAMA; 2016 Mar; 315(9):877-88. PubMed ID: 26906014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial].
    Correa MJ; Mariz HA; Andrade LE; Kayser C
    Rev Bras Reumatol; 2014; 54(6):452-8. PubMed ID: 25458027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial).
    Anstey MH; Wibrow B; Thevathasan T; Roberts B; Chhangani K; Ng PY; Levine A; DiBiasio A; Sarge T; Eikermann M
    BMC Anesthesiol; 2017 Mar; 17(1):47. PubMed ID: 28327122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria.
    Koeze J; Keus F; Dieperink W; van der Horst IC; Zijlstra JG; van Meurs M
    BMC Nephrol; 2017 Feb; 18(1):70. PubMed ID: 28219327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study.
    Molnár Z; Shearer E; Lowe D
    Crit Care Med; 1999 Jun; 27(6):1100-4. PubMed ID: 10397212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.
    Kimmel M; Butscheid M; Brenner S; Kuhlmann U; Klotz U; Alscher DM
    Nephrol Dial Transplant; 2008 Apr; 23(4):1241-5. PubMed ID: 18174269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial.
    Kitzler TM; Jaberi A; Sendlhofer G; Rehak P; Binder C; Petnehazy E; Stacher R; Kotanko P
    Wien Klin Wochenschr; 2012 May; 124(9-10):312-9. PubMed ID: 22527829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial.
    Pickkers P; Heemskerk S; Schouten J; Laterre PF; Vincent JL; Beishuizen A; Jorens PG; Spapen H; Bulitta M; Peters WH; van der Hoeven JG
    Crit Care; 2012 Jan; 16(1):R14. PubMed ID: 22269279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction in the incidence of acute kidney injury after aortic arch surgery with low-dose atrial natriuretic peptide: a randomised controlled trial.
    Mori Y; Kamada T; Ochiai R
    Eur J Anaesthesiol; 2014 Jul; 31(7):381-7. PubMed ID: 24384584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair-a randomized controlled trial.
    Macedo E; Abdulkader R; Castro I; Sobrinho AC; Yu L; Vieira JM
    Nephrol Dial Transplant; 2006 Jul; 21(7):1863-9. PubMed ID: 16522657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients.
    Haase M; Haase-Fielitz A; Bagshaw SM; Reade MC; Morgera S; Seevenayagam S; Matalanis G; Buxton B; Doolan L; Bellomo R
    Crit Care Med; 2007 May; 35(5):1324-31. PubMed ID: 17414730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of online blood volume and blood temperature monitoring during haemodialysis in critically ill patients with acute kidney injury: a single-centre randomized controlled trial.
    du Cheyron D; Terzi N; Seguin A; Valette X; Prevost F; Ramakers M; Daubin C; Charbonneau P; Parienti JJ
    Nephrol Dial Transplant; 2013 Feb; 28(2):430-7. PubMed ID: 22535635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of N-acetylcysteine on pulmonary functions in patients undergoing on-pump coronary artery surgery: a double blind placebo controlled study.
    Erdil N; Eroglu T; Akca B; Disli OM; Yetkin O; Colak MC; Erdil F; Battaloglu B
    Eur Rev Med Pharmacol Sci; 2016; 20(1):180-7. PubMed ID: 26813472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study.
    Farokhnia M; Azarkolah A; Adinehfar F; Khodaie-Ardakani MR; Hosseini SM; Yekehtaz H; Tabrizi M; Rezaei F; Salehi B; Sadeghi SM; Moghadam M; Gharibi F; Mirshafiee O; Akhondzadeh S
    Clin Neuropharmacol; 2013; 36(6):185-92. PubMed ID: 24201233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial.
    Molnar Z; Szakmany T; Koszegi T
    Intensive Care Med; 2003 May; 29(5):749-55. PubMed ID: 12682719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.